You are here
Division of Endocrinology
Project |
Investigator |
All Organizations |
Start date |
End date |
Determination and optimization of the mechanism of action for efficacy of Gleevec in the type I diabetes NOD mouse model |
Jeffrey Bluestone, PhD |
Division of Endocrinology |
|
|
Repertoire analysis of T cells in T1D |
Jeffrey Bluestone, PhD |
Division of Endocrinology |
|
|
Spontaneous Autoimmune Model of Peripheral Neuropathy |
Jeffrey Bluestone, PhD |
Division of Endocrinology |
|
|
Multiple Approach to Study Type 1 Diabetes with Residual C-Peptide |
Jeffrey Bluestone, PhD |
Division of Endocrinology |
|
|
Immune modulation for the treatment of type 1 diabetes |
Jeffrey Bluestone, PhD |
Division of Endocrinology |
|
|
Tolerance induction using engineered stem cell-specific regulatory T cells |
Jeffrey Bluestone, PhD |
Division of Endocrinology |
|
|
DDT and PBDE Exposure, Puberty Onset, and Neurodevelopment in 9-Year-Old Children |
Robert Lustig, MD |
Division of Endocrinology |
|
|
CD4+ FoxP3 lineage cells in CNS autoimmune disease and therapy |
Jeffrey Bluestone, PhD |
Division of Endocrinology |
|
|
Metabolic Impact of Fructose Restriction in Obese Children |
Robert Lustig, MD |
Division of Endocrinology |
|
|
Immunomodulation of transplant rejection by anti-CD3 mAb |
Jeffrey Bluestone, PhD |
Division of Endocrinology |
|
|